What antibiotics are used to treat Enterococcus faecalis infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotics for Treating Enterococcus faecalis Infections

For Enterococcus faecalis infections, ampicillin is the first-line antibiotic treatment, with combination therapy often required depending on the infection site and severity. 1

First-Line Treatment Options

Penicillin-Susceptible E. faecalis

  • Ampicillin: 2g IV every 4 hours (first choice) 2, 1
  • Aqueous crystalline penicillin G: 24 million units/24h IV continuously or in 6 equally divided doses 2

Combination Therapy Based on Susceptibility

  1. Ampicillin + Gentamicin: For synergistic bactericidal activity

    • Gentamicin: 3 mg/kg/day IV/IM in 3 divided doses 2, 1
    • Target gentamicin levels: 1-hour concentration ~3 μg/mL, trough <1 μg/mL 1
  2. Ampicillin + Ceftriaxone: For strains with high-level aminoglycoside resistance

    • Ceftriaxone: 2g IV every 12 hours 2
    • This double β-lactam regimen avoids aminoglycoside toxicity 2, 1
  3. Ampicillin + Streptomycin: For gentamicin-resistant strains

    • Streptomycin: 15 mg/kg/day IV/IM in 2 divided doses 2
    • Target streptomycin levels: 1-hour concentration 20-35 μg/mL, trough <10 μg/mL 2

Alternative Treatments for Resistant Strains

Penicillin-Resistant E. faecalis

  • Vancomycin: 30 mg/kg/day IV in 2 divided doses 2
    • Plus gentamicin or streptomycin for synergistic effect
    • Target vancomycin trough: 10-20 μg/mL 2

Vancomycin-Resistant E. faecalis (VRE)

  1. Linezolid: 600 mg IV/oral every 12 hours 2, 3, 4

    • Effective against both E. faecalis and E. faecium
    • Monitor for thrombocytopenia with prolonged use (>14 days) 3
  2. Daptomycin: 8-12 mg/kg/day IV once daily 1, 5, 3

    • Higher doses recommended for serious enterococcal infections 1
    • Monitor weekly creatine kinase levels 1, 5
    • Consider combination with ampicillin for synergistic effect 5
  3. Teicoplanin: Effective against some vancomycin-resistant strains 4, 6

    • Not available in the United States

Treatment Duration

  • Uncomplicated infections: 7-14 days 1
  • Bloodstream infections with central venous catheters: 10-14 days 1
  • Endocarditis:
    • Native valve: 4 weeks if symptoms <3 months; 6 weeks if symptoms >3 months 2
    • Prosthetic valve: Minimum 6 weeks 2, 1

Special Considerations

β-lactamase-Producing Strains

  • Ampicillin-sulbactam: 3g IV every 6 hours 2
  • These strains are rare but should be tested for when treatment fails 2

Intrinsic Resistance Patterns

  • E. faecalis is intrinsically resistant to:
    • Cephalosporins (monotherapy) 2, 1
    • Trimethoprim-sulfamethoxazole
    • Clindamycin
    • Aminoglycosides (low-level resistance)

Monitoring Recommendations

  • Weekly renal function tests with aminoglycoside therapy 1
  • Weekly complete blood counts with linezolid therapy 3
  • Weekly CK levels with daptomycin therapy 1, 5
  • Follow-up blood cultures to ensure clearance of bacteremia 1

Catheter Management

  • Remove infected catheters immediately for enterococcal bloodstream infections 1
  • New catheter placement should only occur after blood cultures clear 1

Common Pitfalls

  1. Using cephalosporins as monotherapy (intrinsic resistance) 2, 1
  2. Failing to test for high-level aminoglycoside resistance before combination therapy 2
  3. Inadequate duration of therapy, especially for endocarditis 2, 1
  4. Not removing infected catheters, leading to persistent bacteremia 1
  5. Inadequate dosing of daptomycin for serious enterococcal infections 1, 3

For serious or complicated enterococcal infections, especially endocarditis or VRE infections, infectious disease consultation is strongly recommended to guide optimal therapy 2, 1.

References

Guideline

Treatment of Enterococcus faecalis Bloodstream Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antibiotic Resistance in Enterococcus faecalis Isolated from Hospitalized Patients.

Journal of dental research, dental clinics, dental prospects, 2013

Research

Contribution of animal models in the search for effective therapy for endocarditis due to enterococci with high-level resistance to gentamicin.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.